Now, 28% off screening for viral hepatitis B and C and liver fibrosis risk assessment

The liver has a remarkable ability to regenerate, but it can be affected by multiple factors: viral hepatitis B and C, hepatic steatosis (fatty liver disease), type 2 diabetes, obesity, metabolic syndrome, excessive alcohol consumption or other chronic liver diseases.

⚠️ Hepatitis is inflammation of the liver that can affect its ability to perform vital functions in the body, from processing substances to regulating metabolism.

⚠️ One of the consequences of chronic hepatitis and other liver conditions can be liver fibrosis, the gradual replacement of healthy liver tissue with fibrous (scar) tissue, which reduces normal liver function.

In recognition of World Hepatitis Day, we are launching a 28% discount offer for the screening for viral hepatitis B and C and liver fibrosis risk assessment, both from a single blood sample 🧪🩸

Who is it recommended for? What tests does it include? How can you assess the risk?
See the screening description here.

Promotion period | July 20th, 2026 – August 16th, 2026
📍 Available at all Invitro Diagnostics branches.